A VIRTUAL DISCUSSION March 23 at 7:30pm   3rd Annual House Call with Dr. David Lieberman The long awaited FDA decision regarding Trofinetide is scheduled to be announced prior to this meeting.  Dr. Lieberman will discuss what this decision means for the Rett community.  He will also address the upcoming and very exciting gene therapy trials for Rett syndrome.   This is…